Everest Organics informs about press release

12 Oct 2021 Evaluate
Everest Organics has informed that it enclosed the Press Release for successful development of 'Molnupiravir' API, an additional COVID 19 treatment drug for patients with mild and moderate symptoms. 

The above information is a part of company’s filings submitted to BSE.

Everest Organics Share Price

306.25 21.00 (7.36%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×